The impact of individual donation NAT screening on blood safety - the South African experience

被引：8
作者：
Heyns, A. D. P. [1 ]
Swanevelder, J. P. [1 ]
Lelie, P. N. [2 ]
Crookes, R. L. [1 ]
Busch, M. P. [3 ]
机构：
[1] South African Natl Blood Serv, Garsfontein, South Africa
[2] Chiron Corp, Paris, France
[3] Blood Syst Res Inst, San Francisco, CA USA
来源：
ISBT SCIENCE SERIES, VOL 1, NO 1: STATE OF THE ART PRESENTATIONS | 2006年 / 1卷 / 01期
关键词：
D O I：
10.1111/j.1751-2824.2006.00030.x
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：203 / +
页数：2
相关论文
共 16 条
[1]  
Bateman C, 2005, SAMJ S AFR MED J, V95, P202
[2]   Blood safety - At what cost? [J].
Bekker, LG ;
Wood, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (05) :557-558
[3]   A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors [J].
Busch, MP ;
Glynn, SA ;
Stramer, SL ;
Strong, DM ;
Caglioti, S ;
Wright, DJ ;
Pappalardo, B ;
Kleinman, SH .
TRANSFUSION, 2005, 45 (02) :254-264
[4]  
Connolly C, 2004, SAMJ S AFR MED J, V94, P776
[5]   Finding blood donors: challenges facing donor recruitment in South Africa [J].
de Coning, D .
VOX SANGUINIS, 2004, 87 :168-171
[6]  
*DEP HLTH, NAT HIV SYPH ANT SER
[7]   Human immunodeficiency virus-1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing [J].
Fang, CT ;
Field, SP ;
Busch, MP ;
Heyns, AD .
VOX SANGUINIS, 2003, 85 (01) :9-19
[8]   International application of the incidence rate/window period model [J].
Glynn, SA ;
Kleinman, SH ;
Wright, DJ ;
Busch, MP .
TRANSFUSION, 2002, 42 (08) :966-972
[9]   Prevalence of HIV-1 in blood donations following implementation of a structured blood safety policy in South Africa [J].
Heyns, AD ;
Benjamin, RJ ;
Swanevelder, JPR ;
Laycock, ME ;
Pappalardo, BL ;
Crookes, RL ;
Wright, DJ ;
Busch, MP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (05) :519-526
[10]   New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes [J].
Janssen, RS ;
Satten, GA ;
Stramer, SL ;
Rawal, BD ;
O'Brien, TR ;
Weiblen, BJ ;
Hecht, FM ;
Jack, N ;
Cleghorn, FR ;
Kahn, JO ;
Chesney, MA ;
Busch, MP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (01) :42-48
12